Zoom in to a Post ASCO Update on The Evolving Role of ctDNA in the Management of Colon Cancer

The Personalized Medicine Foundation and CancerConnect are pleased to provide physicans the opportunity to Zoom in to a Post ASCO Update on The Evolving Role of ctDNA in the Management of Colon Cancer.

ctDNA is changing the management of colon cancer and this interactive program outlines how ctDNA is shaping colon cancer care and focuses on the role of ctDNA in the evaluation and monitoring of colon cancer and its treatment. The program is hosted and moderated by Drs John Strickler and Tanios Saab throughout the summer and fall at predetermined times giving physicians the opportunity to select a time that works with their schedule.

Each program last 45 mintues to an hour and consists of

  • An overview of ctDNA in the management of colon cancer
  • Interactive case discussions – physicians are encouraged to submit their cases.

Dr. John Strickler, M.D. Associate Professor of Medicine, Associate Director Clinical Research – GI Oncology, Co-Leader, Duke Cancer Institute Molecular Tumor Board, Duke University.

Dr Tanios Bekaii-Saab, MD FACP Head-Mayo Clinic Gastrointestinal Cancer Program & Director of Cancer Clinical Research.

Program Dates and Registration

June 16th 6:30 EST

    June 22nd 6:30 EST

      June 24th 6:30 PST

        July 7th 6:30 EST

          %d bloggers like this: